CA Patent
CA2579732C — Tablets with site time-controlled gastrointestinal release of active ingredient
Assigned to Jagotec AG · Expires 2014-08-12 · 12y expired
What this patent protects
The present invention describes a pharmaceutical dosage form with site~ and time-controlled gastrointestinal release of active ingredient.
USPTO Abstract
The present invention describes a pharmaceutical dosage form with site~ and time-controlled gastrointestinal release of active ingredient.
Drugs covered by this patent
- Deltasone (prednisone) · Generic (originally Schering)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.